SEARCH

SEARCH BY CITATION

References

  • Adam BD, Maticka-Tyndale E & Cohen JJ (2003) Adherence practices among people living with HIV. AIDS Care15, 263274.
  • Adeneye AK, Adewole TA, Musa AZ et al. (2006) Limitations to access and use of antiretroviral therapy (ART) among HIV positive persons in Lagos, Nigeria. World Health & Population8, 4656.
  • Akhila JS, Arbind KC, Chandrashekar R et al. (2010) Factors affecting adherence to highly active anti retroviral therapy in HIV positive patients – Southern India. Journal of Clinical and Diagnostic Research4, 28752877.
  • Altice FL, Mostashari F & Friedland GH (2001) Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes28, 4758.
  • Amico K, Toro-Alfonso J & Fisher JD (2005) An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care17, 661673.
  • Aspeling HE & Van Wyk NC (2008) Factors associated with adherence to antiretroviral therapy for the treatment of HIV-infected women attending an urban care facility. International Journal of Nursing Practice14, 310.
  • Bartlett JA & Shao JF (2009) Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. The Lancet Infectious Diseases9, 637649.
  • Catz SL, Kelly JA, Bogart LM, Benotsch EG & McAuliffe TL (2000) Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology19, 124133.
  • Cauldbeck MB, O’Connor C, O’Connor MB et al. (2009) Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Research and Therapy6, 7.
  • Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G & Goemaere E (2004) Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS18, S27S31.
  • Cooper V, Gellaitry G, Hankins M, Fisher M & Horne R (2009) The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study. AIDS Care21, 520528.
  • CRD (2009). Undertaking Systematic Reviews of Research on Effectiveness: CRD’s Guidance for those Carrying Out or Commissioning Reviews. Centre for Reviews and Dissemination, University of York, York.
  • DiMatteo MR (2004) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology-Dillsdale23, 207218.
  • Dixon-Woods M, Agarwal S, Jones D, Young B & Sutton A (2005) Synthesising qualitative and quantitative evidence: a review of possible methods. Journal of Health Services Research & Policy10, 45.
  • DoH (2001) Better Prevention, Better Services, Better Sexual Health: the National Strategy for Sexual Health and HIV. Department of Health, London.
  • Falagas ME, Zarkadoulia EA, Pliatsika PA & Panos G (2008) Socioeconomic status(SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology5, 13.
  • Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO & Saag MS (2002) Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care14, 607617.
  • Han N, Phoolcharoen W & Perngparn U (2009) Antiretroviral drug taking in HIV positive among Myanmar migrants in central area of Thailand. Journal of Health Research23, 3336.
  • Harden A & Thomas J (2005) Methodological issues in combining diverse study types in systematic reviews. International Journal of Social Research Methodology8, 257271.
  • Hawker S, Payne S, Kerr C, Hardey M & Powell J (2002) Appraising the evidence: reviewing disparate data systematically. Qualitative Health Research12, 1284.
  • Hendershot C, Stoner S, Pantalone D & Simoni J (2009) Alcohol use and antiretroviral adherence: review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes52, 180202.
  • Ickovics JR & Meade CS (2002a) Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. Journal of Acquired Immune Deficiency Syndromes31, S98S102.
  • Ickovics JR & Meade CS (2002b) Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care14, 309318.
  • Irwin AC, Millen JV & Fallows D (2003) Global AIDS: Myths and Facts: Tools for Fighting the AIDS Pandemic. South End Press, Canada.
  • Kgatlwane J, Action B, Ogenyi R, Ekezie C, Madaki H & Moyo S (2005) Factors that Facilitate or Constrain Adherence to Antiretroviral Therapy among Adults at Four Public Health Facilities in Botswana: A Pre-Intervention Study. World Health Organization, Geneva.
  • Konkle-Parker DJ, Erlen JA & Dubbert PM (2008) Barriers and facilitators to medication adherence in a southern minority population with HIV disease. Journal of the Association of Nurses in AIDS Care19, 98104.
  • Kumarasamy N, Safren SA, Raminani SR et al. (2005) Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care & STDs19, 526537.
  • Lewis MP, Colbert A, Erlen J & Meyers M (2006) A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care18, 140148.
  • Li L, Lee SJ, Wen Y, Lin C, Wan D & Jiraphongsa C (2010) Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nursing and Health Sciences12, 212220.
  • Lopez E, Jones D, Ishii M, Tobin J & Weiss S (2007) HIV medication adherence and substance use: the smartest women’s project. American Journal of Infectious Diseases3, 240247.
  • Malta M, Strathdee SA, Magnanini MMF & Bastos FI (2008) Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction103, 12421257.
  • Melbourne K, Abbaticola M, Rana K & Fisher A (1998). Tolerability and body composition of HIV-infected individuals on ritonavir-containing regimens. 38th Interscience Conference on Antimicrobial Activity and Chemotherapy.
  • Mills E, Nachega J, Bangsberg D et al. (2006a) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med3, e438.
  • Mills E, Nachega J, Buchan I et al. (2006b) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Journal American Medical Association296, 679690.
  • Mulrow C (1994) Systematic reviews: rationale for systematic reviews. British Medical Journal309, 597599.
  • Murray L, Semrau K, McCurley E et al. (2009) Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care21, 7886.
  • Naik E, Casanas B, Pazare A, Wabale G, Sinnott J & Salihu H (2009) Cost of treatment: the single biggest obstacle to HIV/AIDS treatment adherence in lower-middle class patients in Mumbai, India. Indian Journal of Sexually Transmitted Diseases30, 2327.
  • Nordqvist O, Södergård B, Tully M, Sönnerborg A & Lindblad Å (2006) Assessing and achieving readiness to initiate HIV medication. Patient Education and Counseling62, 2130.
  • Pawson R (2008) Method mix, technical hex, theory fix. In: Advances in Mixed Methods Research (ed. MM Bergman) Sage, London, pp. 120137.
  • Rao D, Kekwaletswe TC, Hosek S, Martinez J & Rodriguez F (2007) Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care19, 2833.
  • Ruanjahn G, Roberts D & Monterosso L (2010) An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand. AIDS Care22, 15551561.
  • Sabin LL, DeSilva MB, Hamer DH et al. (2008) Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care20, 12421250.
  • Safren S, Kumarasamy N, James R, Raminani S, Solomon S & Mayer K (2005) ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care17, 853862.
  • Sanjobo N, Frich J & Fretheim A (2009) Barriers and facilitators to patients\’adherence to antiretroviral treatment in Zambia: a qualitative study. Journal of Social Aspects of HIV/AIDS Research Alliance5, 136.
  • Sarna A, Pujari S, Sengar AK et al. (2008) Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian Journal of Medical Research127, 2836.
  • Shah B, Walshe L, Saple DG et al. (2007) Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clinical Infectious Diseases44, 12351244.
  • Sharma M, Singh RR, Laishram P et al. (2007) Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment. International Journal of Drug Policy18, 319325.
  • Simoni J, Pearson C, Pantalone D, Marks G & Crepaz N (2006) Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. JAIDS Journal of Acquired Immune Deficiency Syndromes43, S23.
  • Sogarwal R & Bachani D (2009) Assessment of ART centres in India: client perspectives. Journal of the Indian Medical Association107, 276280.
  • Spire B, Carrieri P, Sopha P et al. (2008) Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antiviral Therapy13, 697703.
  • Starks H, Simoni J, Zhao H et al. (2008) Conceptualizing antiretroviral adherence in Beijing, China. AIDS Care20, 607614.
  • Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N & Weiser SD (2009) Transportation costs impede sustained adherence and access to HAART in a clinic population in Southwestern Uganda: a qualitative study. AIDS and Behavior14, 17.
  • Venkatesh K, Srikrishnan A, Mayer K et al. (2010) Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care and STDs24, 795803.
  • Wanchu A, Kaur R, Bambery P & Singh S (2007) Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India. AIDS and Behavior11, 99102.
  • Wang X & Wu Z (2007) Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS21, S149S155.
  • Wang H, He G, Li X et al. (2008) Self-Reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care & STDs22, 7180.
  • Wang H, Zhou J, He G et al. (2009) Consistent ART adherence is associated with improved quality of life, CD4 counts, and reduced hospital costs in central China. AIDS Research and Human Retroviruses25, 757763.
  • Wilson HS, Hutchinson SA & Holzemer WL (2002) Reconciling incompatibilities: a grounded theory of HIV medication adherence and symptom management. Qualitative Health Research12, 1309.
  • WorldBank (2010). World Bank list of economies. [December 2010]; Available from: http://siteresources.worldbank.org/DATASTATISTICS/ (accessed 10 December 2010) Resources/CLASS.XLS.